145 related articles for article (PubMed ID: 31977485)
41. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.
Bodet-Milin C; Faivre-Chauvet A; Carlier T; Ansquer C; Rauscher A; Frampas E; Toulgoat F; Masson D; Bourgeois M; Cerato E; Rohmer V; Couturier O; Drui D; Goldenberg DM; Sharkey RM; Barbet J; Kraeber-Bodere F
J Nucl Med; 2021 Sep; 62(9):1221-1227. PubMed ID: 33547213
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK
Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605
[TBL] [Abstract][Full Text] [Related]
43. Dual-Time-Point
Broos WAM; Wondergem M; van der Zant FM; Knol RJJ
J Nucl Med; 2019 Nov; 60(11):1605-1610. PubMed ID: 30877179
[No Abstract] [Full Text] [Related]
44. 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.
Koopmans KP; de Groot JW; Plukker JT; de Vries EG; Kema IP; Sluiter WJ; Jager PL; Links TP
J Nucl Med; 2008 Apr; 49(4):524-31. PubMed ID: 18375923
[TBL] [Abstract][Full Text] [Related]
45. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
Hoegerle S; Altehoefer C; Ghanem N; Brink I; Moser E; Nitzsche E
Eur J Nucl Med; 2001 Jan; 28(1):64-71. PubMed ID: 11202454
[TBL] [Abstract][Full Text] [Related]
46. Preliminary evaluation of cerebral
Domenech Brasero B; Mestre-Fusco A; Suárez Piñera M; Puertas Calvo E; Perich Alsina X; Montes G; Plaza López P
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(4):214-221. PubMed ID: 34218883
[TBL] [Abstract][Full Text] [Related]
47. Parathyroid Glands Hyperplasias Mimicking Medullary Thyroid Carcinoma Metastatic Lymph Nodes on 18F-DOPA PET/CT.
Terroir M; Grimaldi S; Hartl D; Leboulleux S; Deandreis D
Clin Nucl Med; 2019 Aug; 44(8):e497-e498. PubMed ID: 31274634
[TBL] [Abstract][Full Text] [Related]
48.
Souteiro P; Gouveia P; Ferreira G; Belo S; Costa C; Carvalho D; Duarte H; Sampaio IL
Endocrine; 2019 May; 64(2):322-329. PubMed ID: 30684230
[TBL] [Abstract][Full Text] [Related]
49. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
[TBL] [Abstract][Full Text] [Related]
50. The Role of [18F]F-DOPA PET/CT in Diagnostic and Prognostic Assessment of Medullary Thyroid Cancer: A 15-Year Experience with 109 Patients.
Zhang Z; Yu J; Rainer E; Hargitai L; Jiang Z; Karanikas G; Traub-Weidinger T; Crevenna R; Hacker M; Li S
Eur Thyroid J; 2024 Jun; ():. PubMed ID: 38900599
[TBL] [Abstract][Full Text] [Related]
51. Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer.
Wu D; Plyku D; Kulkarni K; Garcia C; Atkins F; Tefera E; Burman KD; Wartofsky L; Van Nostrand D
Clin Nucl Med; 2021 Apr; 46(4):283-288. PubMed ID: 33492859
[TBL] [Abstract][Full Text] [Related]
52. Role of [(18)F]FDG-PET/CT in the detection of occult recurrent medullary thyroid cancer.
Skoura E; Rondogianni P; Alevizaki M; Tzanela M; Tsagarakis S; Piaditis G; Tolis G; Datseris IE
Nucl Med Commun; 2010 Jun; 31(6):567-75. PubMed ID: 20335822
[TBL] [Abstract][Full Text] [Related]
53. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
54.
Wondergem M; van der Zant FM; Knol RJJ; Lazarenko SV; Pruim J; de Jong IJ
J Nucl Med; 2017 Nov; 58(11):1797-1804. PubMed ID: 28450569
[TBL] [Abstract][Full Text] [Related]
55. 18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports.
Evangelista L; Farsad M; Piotto A; Pelizzo MR
Curr Radiopharm; 2014; 7(2):133-7. PubMed ID: 25355429
[TBL] [Abstract][Full Text] [Related]
56. The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Rubello D; Rampin L; Nanni C; Banti E; Ferdeghini M; Fanti S; Al-Nahhas A; Gross MD
Eur J Surg Oncol; 2008 May; 34(5):581-6. PubMed ID: 17892923
[TBL] [Abstract][Full Text] [Related]
57. The role of
Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
[TBL] [Abstract][Full Text] [Related]
58.
Yamaga LYI; Cunha ML; Campos Neto GC; Garcia MRT; Yang JH; Camacho CP; Wagner J; Funari MBG
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1695-1701. PubMed ID: 28429044
[TBL] [Abstract][Full Text] [Related]
59. Optimization of scan initiation timing after
Nakajima R; Abe K; Momose M; Fukushima K; Matsuo Y; Kimura K; Kondo C; Sakai S
Ann Nucl Med; 2017 Feb; 31(2):190-197. PubMed ID: 27885545
[TBL] [Abstract][Full Text] [Related]
60. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Ozkan ZG; Kuyumcu S; Uzum AK; Gecer MF; Ozel S; Aral F; Adalet I
Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]